Suppr超能文献

[上海某综合医院急诊重症监护病房医院获得性艰难梭菌感染及定植的流行病学与危险因素]

[Epidemiology and risk factors for hospital acquired Clostridium difficile infection and colonization in emergency intensive care unit of a general hospital in Shanghai].

作者信息

Yu Meiling, Zhao Bing, Chen Ying, Sheng Huiqiu, Chen Erzhen, Yang Zhitao, Mao Enqiang

机构信息

Department of Emergency Intensive Care Unit, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. Corresponding author: Mao Enqiang, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Nov;33(11):1358-1361. doi: 10.3760/cma.j.cn121430-20210520-00748.

Abstract

OBJECTIVE

To investigate the clinical features, risk factors and prognosis of Clostridium difficile infection/colonization (CDI/CDC) in emergency intensive care unit (EICU) of Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, then provides theoretical basis for clinical treatment.

METHODS

A retrospective case-control study was conducted. The data of EICU patients admitted to Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine from June 2016 to June 2020 were collected. Taking the CDI/CDC patients as research objects [Clostridium difficile (CD) positive group] and the CD negative patients with the same gender and age difference less than 5 years who were admitted to the hospital during the same period as the control (CD negative group). Demographic information, risk factors, prognosis and stool samples were collected. Single factor analysis and binary Logistic regression were used to analyze the CD positive infection rate, risk factors, and hospital death of patients with different clinical characteristics.

RESULTS

About 487 patients in EICU were included, 76 cases were taken into CD positive group, CD positive rate was 15.6%, including CDI 11 cases, CDC 65 cases. Among the CD positive group, all of the cases used proton pump inhibitor (PPI), and 75 cases used at least one antibiotic. Seventy-six CD negative patients with or without diarrhea (CD negative group) were included in this study. Among them, 75 patients used PPI and 74 patients used at least one antibiotic. Univariate analysis showed that acute physiology and chronic health evaluation II (APACHE II), duration of hospitalization, and carbapenem use were the risk factors for CDI/CDC. There were significant differences in the above indicators between CD positive group and CD negative group [APACHE II: 18.0 (12.2, 25.8) vs. 10.0 (7.0, 14.0), duration of hospitalization (days): 46.0 (30.5, 72.5) vs. 18.5 (9.2, 37.0), proportion of carbapenems: 81.6% (62/76) vs. 64.5% (49/76), all P < 0.05]. Binary Logistic analysis regression analysis showed that APACHE II score [odds ratio (OR) = 0.802, 95% confidence interval (95%CI) was 0.730-0.882, P < 0.01] and duration of hospitalization (OR = 0.960, 95%CI was 0.942-0.978, P < 0.01) were independent risk factors for CDI/CDC. There was no difference in overall mortality between the CD positive group and CD negative group [27.6% (21/76) vs. 38.2% (29/76), P = 0.167].

CONCLUSIONS

Critically ill patients in EICU routinely use PPI and antibiotics, and the use of antibiotics does not affect the CD positive rate. The independent risk factors of CDI/CDC are the APACHE II score and the duration of hospitalization, but fecal CD positive has no obvious influence on death.

摘要

目的

探讨上海交通大学医学院附属瑞金医院急诊重症监护病房(EICU)艰难梭菌感染/定植(CDI/CDC)的临床特征、危险因素及预后,为临床治疗提供理论依据。

方法

进行一项回顾性病例对照研究。收集2016年6月至2020年6月在上海交通大学医学院附属瑞金医院EICU住院患者的数据。以CDI/CDC患者为研究对象[艰难梭菌(CD)阳性组],选取同期入院的性别相同、年龄相差不超过5岁的CD阴性患者作为对照(CD阴性组)。收集人口学信息、危险因素、预后情况及粪便样本。采用单因素分析和二元Logistic回归分析不同临床特征患者的CD阳性感染率、危险因素及院内死亡情况。

结果

共纳入EICU患者约487例,76例纳入CD阳性组,CD阳性率为15.6%,其中CDI 11例,CDC 65例。CD阳性组中,所有病例均使用质子泵抑制剂(PPI),75例使用过至少一种抗生素。本研究纳入76例有或无腹泻的CD阴性患者(CD阴性组)。其中,75例使用PPI,74例使用过至少一种抗生素。单因素分析显示,急性生理与慢性健康状况评分系统II(APACHE II)、住院时间及碳青霉烯类药物的使用是CDI/CDC的危险因素。CD阳性组与CD阴性组上述指标比较差异有统计学意义[APACHE II:18.0(12.2,25.8)比10.0(7.0,14.0),住院时间(天):46.0(30.5,72.5)比18.5(9.2,37.0),碳青霉烯类药物使用比例:81.6%(62/76)比64.5%(49/76),均P<0.05]。二元Logistic回归分析显示,APACHE II评分[比值比(OR)=0.802,95%置信区间(95%CI)为0.730 - 0.882,P<0.01]及住院时间(OR = 0.960,95%CI为0.942 - 0.978,P<0.01)是CDI/CDC的独立危险因素。CD阳性组与CD阴性组总体死亡率比较差异无统计学意义[27.6%(21/76)比38.2%(29/76),P = 0.167]。

结论

EICU重症患者常规使用PPI和抗生素,抗生素的使用不影响CD阳性率。CDI/CDC的独立危险因素是APACHE II评分及住院时间,但粪便CD阳性对死亡无明显影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验